Filing Details
- Accession Number:
- 0001179110-13-017622
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-09 17:25:55
- Reporting Period:
- 2013-12-05
- Filing Date:
- 2013-12-09
- Accepted Time:
- 2013-12-09 17:25:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1573318 | D Charles Foltz | 100 Abbott Park Road Abbott Park IL 60064 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2013-12-05 | 587 | $24.73 | 54,535 | No | 4 | M | Direct | |
Common Shares Without Par Value | Acquisiton | 2013-12-05 | 1,443 | $24.72 | 55,978 | No | 4 | M | Direct | |
Common Shares Without Par Value | Disposition | 2013-12-05 | 1,716 | $37.03 | 54,262 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Disposition | 2013-12-05 | 587 | $0.00 | 587 | $24.73 |
Common Shares | Option (right to buy) | Disposition | 2013-12-05 | 1,443 | $0.00 | 1,443 | $24.72 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-02-12 | 2014-02-19 | No | 4 | M | Direct |
0 | 2011-03-15 | 2014-02-19 | No | 4 | M | Direct |
Footnotes
- Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.